Serum creatinine concentration and risk of cardiovascular disease: A possible marker for increased risk of stroke

Stroke

Volumn 28, Issue 3, 1997, Pages 557-563

  Wannamethee, S Goya ^a   Shaper, A Gerald ^a   Perry, Ivan J ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

cardiovascular disorders; creatinine; mortality; risk factors

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DIAGNOSTIC VALUE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STROKE;

EID: 0030969796     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.3.557     Document Type: Article

References (18)

1. Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG, Schneider KA. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function: results from the Hypertension Detection and Follow-up Program. Hypertension. 1989;13(suppl I):I-80-I-93.
2. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. BMJ. 1990;300:297-300.
3. Friedman PJ. Serum creatinine: an independent predictor of survival after stroke. J Intern Med. 1991;229:175-179.
4. Matts JP, Karnegis JN, Campos CT, Fitch LE, Johnson JW, Buchwald H, and Posch Group. Serum creatinine as an independent predictor of coronary heart disease mortality in normotensive survivors of myocardial infarction. J Fam Pract. 1993;36: 497-503.
5. Shaper AG, Pocock SJ, Walker M, Cohen NM, Wale CJ, Thomson AG. British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. Br Med J. 1981;283:179-186.
6. Shaper AG, Wannamethee G, Walker M. Alcohol and mortality in British men: explaining the U-shaped curve. Lancet. 1988;2: 1266-1273.
7. Shaper AG, Wannamethee G. Physical activity and ischemic heart disease in middle-aged British men. Br Heart J. 1991;66:384-394.
8. Bruce NG, Shaper AG, Walker M, Wannamethee G. Observer bias in blood pressure studies. J Hypertens. 1988;6:375-380.
9. Cook DG, Shaper AG, MacFarlane PW. Using the WHO (Rose) angina questionnaire in cardiovascular epidemiological studies. Int J Epidemiol. 1989;18:607-613.
10. MacFarlane PW, Melville DI, Horton MR, Bailey JJ. Comparative evaluation of the IBM (12-lead) and the Royal Infirmary (orthogonal 3-lead) ECG computer programs. Circulation. 1981;63:354-359.
11. Walker M, Shaper AG. Follow-up of subjects in prospective studies in general practice. J R Coll Gen Pract. 1984;34:365-370.
12. Cox DR. Regression models and life tables. J R Stat Soc B. 1972; 34:187-220.
13. Walker G, Neaton J, Cutler JA, Neuwirth R, Cohen JD. Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial: racial and treatment effects. JAMA. 1992; 268:3085-3091.
14. Perneger TV, Nieto FJ, Whelton PK, Klag MJ, Comstock GW, Szklo M. A prospective study of blood pressure and serum creatinine: results from the 'Clue' and the ARIC study. JAMA. 1993; 269:488-493.
15. Rosansky SJ, Hoover DR, Kig L, Gibson J. The association of blood pressure levels and change in renal function in hypertensive and non-hypertensive subjects. Arch Intern Med. 1990;150:2073-2076.
16. Neaton J, Wentworth D, Sherwin R, Kittner S, Kuller L, Stamler J. Comparison of 10-year coronary and cerebrovascular disease mortality rates by hypertensive status for black and non-black men screened in the Multiple Risk Factor Intervention Trial (MRFIT). Circulation. 1989;80(suppl II):II-300. Abstract.
17. Rambausek M, Fliser D, Ritz E. Albuminuria of hypertensive patients. Clin Nephrol. 1992;38(suppl 1):S40-S45.
18. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as a predictor of vascular disease in non-diabetic subjects. Lancet. 1988;2:530-533.